Opens in a new tab

Hyperosmolar Hyperglycemic State (HHS): Symptoms, Criteria and Treatment

Table of Content

Smiling older man with diabetes resting in a hospital bed with a relative at his side while a friendly nurse checks his IV fluid drip, a glucose meter and blood test tubes on the bedside table

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

Hyperosmolar hyperglycemic state (HHS) is a diabetes emergency in which blood sugar climbs extremely high, usually to 600 mg/dL (33.3 mmol/L) or more, and the body loses so much water through urine that the blood becomes thick and concentrated. Unlike diabetic ketoacidosis (DKA), there are few or no ketones and no significant acid buildup. HHS mostly affects older adults with type 2 diabetes, often during an infection, and it develops slowly, over days or weeks.

The warning signs are extreme thirst, passing a lot of urine, dry mouth, weakness, then drowsiness and confusion. HHS is treated in the hospital with intravenous fluids, potassium and a low dose of insulin, given slowly and carefully. It is serious: in US hospitals about 5 in 100 people admitted with HHS die, and the risk is higher in frail older adults. If someone with diabetes becomes confused or very drowsy with high blood sugar, call 911.

Key takeaways

  • The 2024 consensus criteria: glucose of at least 600 mg/dL, effective osmolality above 300 mOsm/kg, low ketones, and normal pH with bicarbonate of at least 15 mmol/L.
  • Infection, mostly urinary tract infections and pneumonia, triggers 30 to 60% of cases. Missed diabetes medicines, steroids and some antipsychotics are other triggers.
  • About 1 in 4 US hyperglycemic crises are mixed DKA-HHS, which carries the highest risk of death (about 8%).
  • A sick-day plan, frequent glucose checks and drinking enough fluids are the best ways to prevent HHS.

What is hyperosmolar hyperglycemic state?

HHS is a "hyperglycemic crisis", one of the two most serious short-term complications of diabetes, along with DKA. The 2024 consensus report of the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), the Joint British Diabetes Societies (JBDS), the American Association of Clinical Endocrinology (AACE) and the Diabetes Technology Society (DTS) defines HHS as significant hyperglycemia and hyperosmolality without severe ketonemia or metabolic acidosis.

Older names include hyperosmolar hyperglycemic syndrome and hyperosmolar nonketotic coma. If you need a refresher on the disease itself, our guide to diabetes symptoms, causes and treatment explains how type 1 and type 2 diabetes differ.

What happens in the body

In HHS, the body still makes a little insulin: enough to limit ketone production, so ketoacidosis does not develop, but not enough to control glucose. Glucose rises day after day, spills into the urine and pulls water with it. This "osmotic diuresis" causes large losses of water, sodium and potassium.

As water leaves, the blood becomes more concentrated (hyperosmolar) and water moves out of cells, which is thought to explain the confusion and drowsiness. The JBDS guideline estimates total fluid losses of 100 to 220 mL per kilogram of body weight, which is about 7 to 15 liters for a 154-pound (70 kg) adult. Our page on glucose levels and normal ranges shows how far above normal HHS values are.

Who gets HHS? Causes and risk factors

HHS can occur at any age and with any type of diabetes, but the consensus report says it is most often seen in older adults with type 2 diabetes. In US data, 88.1% of HHS events occurred in people with type 2 diabetes, and 47.5% in adults aged 45 to 64. A 2026 meta-analysis of 63,935 cases found a median age of 63.8 years. Volume depletion is the main driver: older adults have a weaker thirst sense and may have limited access to fluids.

In a Danish nationwide study of 634 people with HHS (median age 69), 32% did not know they had diabetes. HHS was their first sign of the disease.

Common triggers

  • Infection: the major trigger in 30 to 60% of people with HHS, mostly urinary tract infections and pneumonia (consensus report). Our guides to urinary tract infection and pneumonia symptoms and tests describe the signs to watch for.
  • Other acute illnesses: stroke, heart attack, surgery and pancreatitis.
  • Medicines: corticosteroids (steroids), sympathomimetics and antipsychotics are named by the consensus report. Cleveland Clinic also lists thiazide diuretics.
  • Stopping or running out of diabetes medicines: Cleveland Clinic says about 21% of HHS cases involve this.
  • Impaired thirst or limited access to water, two risk factors listed by MedlinePlus, along with heart failure and poor kidney function.

SGLT2 inhibitors and mixed DKA-HHS

SGLT2 inhibitors lower glucose by making the kidneys release more sugar into the urine. The consensus report notes that they raise the risk of DKA, mostly in type 1 diabetes but also in type 2 diabetes, and that this DKA can occur with near-normal glucose. Specific "sick day rules" can help prevent it, and these drugs are stopped on hospital admission. Our article on sugar in urine (glucosuria) explains this effect.

Many crises do not fit neatly in one box. In a US study cited by the consensus report, 35% of hyperglycemic crisis admissions were HHS, 38% DKA and 27% mixed DKA-HHS. Mixed cases have significant ketones or acidosis on top of HHS, and they need the stronger DKA insulin dose.

Symptoms of hyperosmolar hyperglycemic state

HHS creeps up over days or weeks. MedlinePlus describes this progression:

  • Early: increased thirst and frequent urination.
  • Then: weakness, nausea, weight loss, dry mouth and fever.
  • Later: drowsiness, confusion, seizures and coma.

Cleveland Clinic adds blurred vision, hallucinations, and weakness or paralysis that can be worse on one side of the body, which can be mistaken for a stroke. Unlike DKA, nausea, vomiting and belly pain are uncommon in HHS, and there is no fruity breath or deep, rapid "Kussmaul" breathing.

Diagnostic criteria for HHS

Doctors confirm HHS with glucose, electrolytes, a venous blood gas (pH and bicarbonate), ketones, kidney tests and a blood count, then look for the trigger with urine tests, cultures, a chest X-ray and an ECG.

The 2024 consensus report requires all four criteria in the table below. According to a Cleveland Clinic Journal of Medicine review, the main changes from 2009 are a lower effective osmolality threshold (above 300 instead of 320 mOsm/kg), a lower bicarbonate threshold (15 instead of 18 mmol/L), and the removal of altered mental status as a requirement. The UK JBDS guideline uses slightly different numbers: glucose of at least 30 mmol/L (540 mg/dL) and osmolality of at least 320 mOsm/kg.

How to calculate osmolality

Osmolality measures how concentrated the blood is. Labs can measure it directly, or it can be calculated from your sodium blood test and glucose:

  • Effective osmolality = 2 × sodium (mmol/L) + glucose (mg/dL) ÷ 18. In SI units: 2 × sodium + glucose (mmol/L).
  • Total osmolality adds urea: + BUN (mg/dL) ÷ 2.8, or + urea (mmol/L) in SI units. This is the JBDS formula.

Example: sodium 145 mmol/L and glucose 900 mg/dL (50 mmol/L) give 2 × 145 + 50 = 340 mOsm/kg, well above the HHS threshold.

Corrected sodium

Very high glucose pulls water into the blood and dilutes sodium, so the measured sodium can look normal or even low while the person is in fact very dehydrated. The consensus report states that each 100 mg/dL (5.6 mmol/L) drop in glucose raises sodium by about 1.6 mmol/L. Doctors therefore "correct" sodium: corrected sodium = measured sodium + 1.6 × (glucose − 100) ÷ 100. With a measured sodium of 132 mmol/L and glucose of 900 mg/dL, corrected sodium is about 145 mmol/L. A rise in measured sodium during treatment is expected and is not by itself a reason to change fluids.

HHS criteria: reference table (US and SI units)

TestUsual adult rangeHHS criterion (2024 consensus)
Plasma glucose70-99 mg/dL (3.9-5.5 mmol/L) fasting600 mg/dL (33.3 mmol/L) or more
Effective serum osmolalityMeasured osmolality 275-295 mOsm/kgAbove 300 mOsm/kg (2 × Na + glucose)
Total serum osmolality275-295 mOsm/kgAbove 320 mOsm/kg (2 × Na + glucose + urea)
Beta-hydroxybutyrate (blood ketones)Very low when wellBelow 3.0 mmol/L (or urine ketones 2+ or less)
Venous pH7.35-7.457.30 or higher
Bicarbonate22-26 mEq/L (mmol/L)15 mEq/L (mmol/L) or higher; most patients have 18 or more
HHS resolved-Osmolality below 300 mOsm/kg, glucose below 250 mg/dL (13.9 mmol/L), urine output above 0.5 mL/kg/h, alertness improved

Ranges vary between laboratories: compare with your own report. The usual ranges shown come from laboratory references quoted in published case reports; our CO2 blood test (bicarbonate) guide details that marker.

How to read the results

Glucose above 600 mg/dL with low ketones and a normal pH points to HHS. High glucose with ketones of 3.0 mmol/L or more and a low pH points to DKA. When both osmolality and ketones are high, doctors diagnose mixed DKA-HHS. Our article on ketones in urine explains urine strips; blood beta-hydroxybutyrate is the preferred test.

HHS vs DKA: what is the difference?

FeatureHHSDKA
Typical personOlder adult with type 2 diabetesYounger adult with type 1 diabetes (can occur in type 2)
OnsetDays to weeksHours to a few days
Glucose600 mg/dL (33.3 mmol/L) or more200 mg/dL (11.1 mmol/L) or more, or known diabetes
Beta-hydroxybutyrateBelow 3.0 mmol/L3.0 mmol/L or more (or urine ketones 2+ or more)
pH and bicarbonatepH 7.30 or higher, bicarbonate 15 mmol/L or higherpH below 7.30 and/or bicarbonate below 18 mmol/L
OsmolalityEffective above 300 mOsm/kgVariable
Main symptomsThirst, dehydration, confusionNausea, vomiting, belly pain (over 50%), fruity breath, deep fast breathing
Starting insulin infusion0.05 units/kg/h0.1 units/kg/h
US in-hospital mortalityAbout 5% (8% if mixed DKA-HHS)About 3%

How is hyperosmolar hyperglycemic state treated?

HHS is always treated in the hospital. In the 2026 meta-analysis, 40.8% of patients were admitted to intensive care, and 70.0% in North America. The 2024 consensus report organizes treatment around three pillars, fluids, insulin and potassium, plus treatment of the trigger. Glucose is measured every 1 to 2 hours, and electrolytes, creatinine and osmolality every 4 hours.

1. Fluids first

Fluids are the most important treatment. The consensus recommends isotonic saline (0.9% sodium chloride) or a balanced crystalloid at 500 to 1,000 mL per hour for the first 2 to 4 hours, then replacing the estimated deficit over 24 to 48 hours. Older adults and people with heart failure or on dialysis receive smaller boluses (for example 250 mL) with frequent checks. Fluids alone already lower glucose by diluting it and helping the kidneys clear it.

2. A low, slow dose of insulin

Insulin (human regular insulin, ChEMBL CHEMBL1201631) is given as a fixed-rate intravenous infusion starting at 0.05 units/kg per hour in HHS without significant ketones, and 0.1 units/kg per hour in mixed DKA-HHS. The JBDS guideline suggests starting insulin once osmolality stops falling with fluids alone, unless ketones are present. When glucose falls below 250 mg/dL (13.9 mmol/L), 5 to 10% dextrose is added to avoid low blood sugar.

3. Potassium

Insulin pushes potassium into the cells, so blood potassium can drop fast. The consensus advises starting potassium replacement when it falls below 5.0 mmol/L, aiming for 4 to 5 mmol/L. If potassium is below 3.5 mmol/L, insulin is delayed until it is corrected. Low potassium (below 3.5 mmol/L) occurs in 51% of people treated for HHS. Our potassium blood test guide explains these thresholds.

Going slowly protects the brain

Correcting HHS too fast can harm the brain. The consensus recommends that glucose falls by no more than 90 to 120 mg/dL per hour, sodium by no more than 10 mmol/L in 24 hours, and osmolality by 3.0 to 8.0 mOsm/kg per hour. Doctors also give a preventive dose of low-molecular-weight heparin against blood clots unless a clot is already suspected.

Complications of HHS

  • Blood clots: HHS is thought to promote clotting, hence heparin prophylaxis. Read our guide to pulmonary embolism symptoms and tests.
  • Acute kidney injury: in a 2026 US analysis of 80,557 HHS hospitalizations, 56.1% had acute kidney injury, and it usually improves with rehydration (consensus report).
  • Low blood sugar and low potassium during treatment.
  • Cerebral edema (brain swelling): thought to occur in fewer than 0.1% of adult crises, with a reported mortality of about 30%; slow correction of osmolality is the main protection.
  • Osmotic demyelination: nerve damage in the brain linked to overly rapid sodium shifts.
  • Death: about 5% of US HHS admissions, 8% for mixed DKA-HHS. In an Israeli study, raw mortality was 41.2% in HHS (mean age 77) vs 4.7% in DKA, driven mainly by age, other illnesses and infection.

Prevention and sick-day rules

HHS builds over days, which leaves time to act. MedlinePlus recommends controlling type 2 diabetes, watching for early signs of dehydration and infection, following a sick-day plan, and ordering diabetes medicines in 3-month supplies so you do not run out. The CDC sick-day advice adds:

  • Test your blood sugar every 4 hours and keep track of the results.
  • Keep taking your insulin and diabetes pills as usual unless your care team says otherwise. Ask in advance which medicines to pause when you cannot eat or drink, especially SGLT2 inhibitors.
  • Drink plenty of water. If you cannot eat normally, aim for about 50 grams of carbohydrates every 4 hours.
  • Weigh yourself every day and check your temperature morning and evening.
  • Keep a sick-day kit: thermometer, sports drinks, juice or regular soda, crackers, canned soup, and enough diabetes medicines for several weeks.

After a hyperglycemic crisis, the consensus report advises follow-up within 2 to 4 weeks of discharge, an adequate supply of insulin and monitoring devices, and education on sick-day management.

Blood tests after an HHS episode

After the crisis, a few tests help explain what happened:

  • HbA1c: reflects your average blood sugar over the past few months. A very high value suggests glucose had been rising for weeks; a near-normal value suggests a sudden trigger (a drug or an acute illness). See our guide to the HbA1c test and its ranges.
  • Kidney function: creatinine, eGFR and BUN often rise during HHS because of dehydration. They usually improve with rehydration; values that stay high need follow-up. Our article on the BUN (blood urea nitrogen) test explains why BUN climbs with dehydration.
  • Electrolytes: sodium, potassium, chloride and bicarbonate, rechecked after discharge, especially if you take diuretics. Our electrolyte panel guide explains each value.

When to see a doctor

MedlinePlus calls HHS a medical emergency. Call 911 or go to the emergency room if a person with diabetes (or with very high blood sugar) has:

  • confusion, unusual drowsiness, hallucinations, slurred speech, weakness on one side, or a seizure;
  • extreme thirst, very dry mouth and signs of dehydration;
  • trouble breathing.

The CDC also advises going to the emergency room if you cannot keep liquids down for more than 4 hours, have vomiting or severe diarrhea for more than 6 hours, lose 5 pounds or more during an illness, have ketones in your urine, or have a temperature over 101°F for 24 hours.

Latest scientific advances in hyperosmolar hyperglycemic state

New 2024 diagnostic and resolution criteria

The 2024 consensus report, published in Diabetes Care and Diabetologia, is the first update since 2009. It lowered the HHS osmolality and bicarbonate thresholds, no longer requires confusion for the diagnosis, defines HHS resolution for the first time and allows balanced crystalloids. HHS may therefore be recognized before confusion sets in.

The first large global picture of HHS (2026)

A 2026 systematic review and meta-analysis in BMJ Open Diabetes Research and Care pooled 27 studies and 63,935 HHS cases. Infection triggered 44.0% of cases, non-infective illness 49.5%, and a new diabetes diagnosis 31.7%. Overall mortality was 21.1%, ranging from 4.8% in North America to 40.0% in Africa.

Kidneys, sodium and age predict outcomes

A 2026 US Nationwide Inpatient Sample study (80,557 HHS hospitalizations, 2013 to 2022) found that acute kidney injury rose from 45.9% to 63.6% of cases and was linked to higher in-hospital mortality (4.6% vs 1.3%). In the UK DEKODE-HHS surveillance study (218 episodes in 12 hospitals, median age 77), mortality was 16.1%, and older age and higher sodium independently predicted death. Both studies support checking kidney function and sodium closely.

Low blood sugar during treatment matters

A 2024 Spanish cohort of 170 people treated for hyperosmolar crises found low blood sugar in 26.5% during the intravenous insulin phase. It was linked to a doubled long-term risk of death (hazard ratio 2.10). This reinforces the low insulin dose and early dextrose recommended in 2024.

Trials on insulin strategies and glucose sensors

HHS trials remain rare. A phase 2 trial in Taiwan (NCT05155917, 70 participants) tested adding basal insulin glargine under the skin to the insulin drip in hyperglycemic crises, including HHS; its status is listed as unknown. A US study of continuous glucose monitoring with a subcutaneous insulin protocol for mild to moderate DKA or HHS (NCT06693115) was withdrawn before enrolling anyone. Researchers from Israel noted in 2025 that no HHS-specific, evidence-based treatment strategy exists yet.

Which tests can help?

Ask your doctor about:

  • plasma glucose and HbA1c;
  • a basic or comprehensive metabolic panel: sodium, potassium, chloride, bicarbonate, BUN, creatinine and eGFR;
  • measured or calculated serum osmolality;
  • blood beta-hydroxybutyrate (or urine ketones) and a venous blood gas;
  • a urinalysis and urine culture, a complete blood count and, if needed, a chest X-ray to find an infection;

Glossary

  • Osmolality: the concentration of dissolved particles (mainly sodium, glucose and urea) in the blood, in mOsm/kg.
  • Effective osmolality: osmolality from sodium and glucose only (2 × Na + glucose), the substances that move water out of cells.
  • Osmotic diuresis: heavy urine output caused by large amounts of glucose in the urine pulling water with it.
  • Beta-hydroxybutyrate: the main ketone measured in blood; 3.0 mmol/L or more points to ketoacidosis.
  • Mixed DKA-HHS: a crisis with both high osmolality and significant ketones or acidosis.

Frequently asked questions

What are symptoms of hyperosmolar hyperglycemic state?

Strong thirst, frequent urination and dry mouth come first. Over days or weeks, weakness, weight loss, blurred vision and fever follow, then drowsiness, confusion, seizures or coma. Vomiting and belly pain are less common than in DKA.

What are the differences between DKA and HHS?

DKA develops in hours to days, with ketones of 3.0 mmol/L or more and acidic blood, mostly in type 1 diabetes. HHS develops over days to weeks, with glucose of 600 mg/dL or more, high osmolality and little or no ketones, mostly in older adults with type 2 diabetes. About a quarter of crises are mixed.

What are the diagnostic criteria for HHS?

Since 2024, all four are required: glucose of 600 mg/dL (33.3 mmol/L) or more; effective osmolality above 300 mOsm/kg or total osmolality above 320; beta-hydroxybutyrate below 3.0 mmol/L; and pH of 7.30 or more with bicarbonate of 15 mmol/L or more.

How do you treat hyperosmolar hyperglycemic state?

In the hospital: intravenous fluids first, then low-dose insulin (0.05 units/kg per hour), potassium, dextrose once glucose falls below 250 mg/dL, heparin against clots and treatment of the trigger. Everything is corrected slowly to protect the brain.

What is the pathophysiology of HHS?

A relative lack of insulin, plus stress hormones during illness, lets glucose rise and spill into the urine with water, sodium and potassium. Some insulin is still present, so ketones stay low: the problem is severe dehydration, not acid buildup.

Can you get HHS with type 1 diabetes or without knowing you have diabetes?

Yes. HHS can occur with any type of diabetes, even in children. In the Danish nationwide study, 32% of people with HHS had no known diabetes, and HHS was more frequent among people with type 1 than type 2 diabetes.

Sources

  • Umpierrez GE, Davis GM, ElSayed NA et al. — Hyperglycemic crises in adults with diabetes: a consensus report — Diabetes Care, 2024 — doi.org
  • Umpierrez GE, Davis GM, ElSayed NA et al. — Hyperglycaemic crises in adults with diabetes: a consensus report (full text) — Diabetologia, 2024 — pmc.ncbi.nlm.nih.gov
  • Rodriguez Alvarez P, San Martin VT, Morey-Vargas OL — Hyperglycemic crises in adults: a look at the 2024 consensus report — Cleve Clin J Med, 2025 — doi.org
  • Mustafa OG, Haq M, Dashora U et al. — Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group — Diabet Med, 2023 — doi.org
  • French J, Bomphrey L, Manta A et al. — Hyperosmolar hyperglycaemic state: a systematic review and meta-analysis — BMJ Open Diabetes Res Care, 2026 — doi.org
  • Rosager EV, Heltø ALK, Fox Maule CU et al. — Incidence and characteristics of the hyperosmolar hyperglycemic state: a Danish cohort study — Diabetes Care, 2024 — doi.org
  • Lin P, Chen Y, Peng Y et al. — Occurrence, associated factors, and in-hospital outcomes of acute kidney injury in patients hospitalized with hyperosmolar hyperglycemic state (Nationwide Inpatient Sample 2013-2022) — Shock, 2026 — doi.org
  • Kew TM, Manta A, Sawlani JP et al. — Identifying interhospital variation in hyperosmolar hyperglycemic syndrome (HHS) care: the DEKODE HHS model — BMJ Open Diabetes Res Care, 2025 — doi.org
  • González-Vidal T, Lambert C, García AV et al. — Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality — Diabetol Metab Syndr, 2024 — doi.org
  • Shvarts B, Golbets E, Sagy I et al. — Is our understanding of hyperosmolar hyperglycemic state accurate? — J Emerg Med, 2025 — doi.org
  • Filippatos F, Themelis G, Dolianiti M et al. — Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state in a 5-year-old with new-onset type 1 diabetes (pH and bicarbonate reference ranges) — Reports (MDPI), 2026 — doi.org
  • Almallouhi A, Sadek M, Ruby E — Pheochromocytoma presenting with hyperosmolar hyperglycemic state and transient stroke-like deficits (laboratory reference ranges) — JCEM Case Rep, 2026 — doi.org
  • ClinicalTrials.gov — Concurrent subcutaneous basal insulin and intravenous insulin pump in hyperglycemic crisis patients under critical care (NCT05155917) — clinicaltrials.gov
  • ClinicalTrials.gov — Continuous glucose monitoring with a new subcutaneous insulin protocol for mild to moderate DKA or HHS (NCT06693115) — clinicaltrials.gov
  • MedlinePlus — Diabetic hyperglycemic hyperosmolar syndrome — National Library of Medicine, 2026 — medlineplus.gov
  • CDC — Managing sick days (diabetes) — 2024 — cdc.gov
  • Cleveland Clinic — Hyperosmolar hyperglycemic state (HHS) — 2023 — my.clevelandclinic.org
  • EMBL-EBI — ChEMBL: insulin human (CHEMBL1201631) — ChEMBL — ebi.ac.uk

Further reading

Understand your lab results with AI DiagMe

After a hyperglycemic crisis, your lab report is full of numbers: glucose, sodium, potassium, bicarbonate, BUN, creatinine, eGFR and HbA1c. AI DiagMe reads your report in minutes, explains each value in plain language, shows which results have returned to normal and which still need attention, and suggests questions to ask your doctor at your follow-up visit. Upload your lab results to AI DiagMe for a clear, personal report.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon